# Observational Study of the Combination of Post-transplant High Dose Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Acute Graft-versus-Host Disease in Patients Eligible to Allogeneic Hematopoietic Stem Cell Transplant

> **NCT02300571** · — · UNKNOWN · sponsor: **Fondazione del Piemonte per l'Oncologia** · enrollment: 60 (estimated)

## Conditions studied

- Hematological Malignancies

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02300571
- **Lead sponsor:** Fondazione del Piemonte per l'Oncologia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-09
- **Primary completion:** 2017-12
- **Final completion:** 2018-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2017-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02300571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02300571, "Observational Study of the Combination of Post-transplant High Dose Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Acute Graft-versus-Host Disease in Patients Eligible to Allogeneic Hematopoietic Stem Cell Transplant". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT02300571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*